Jennifer L Taubert, EVP, WWC. Innovative Medicine at Johnson & Johnson, sold JNJ on Aug 17, 2026
Data as of Oct 16
▼ SELL$4M15,000 shares at $263.36Jennifer L Taubert EVP, WWC. Innovative MedicineJNJ Johnson & Johnson
- Traded
- Aug 17, 2026
- Disclosed
- Aug 18, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
JNJ since disclosure
−5.7%
after the sale
Similar stocks (XLV) since disclosure
+4.1%
XLV — its sector index fund
Change in closing price from Aug 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.